You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昊海生物科技(06826)獲政府補助共計2821.28萬元
格隆匯 01-12 19:23

格隆匯1月12日丨昊海生物科技(06826)公吿,上海昊海生物科技股份有限公司(以下簡稱“公司”)及公司子公司上海其勝生物製劑有限公司、上海利康瑞生物工程有限公司、上海建華精細生物製品有限公司、河南宇宙人工晶狀體研製有限公司、深圳市新產業眼科新技術有限公司、青島華元精細生物製品有限公司、河南賽美視生物科技有限公司等自2021年1月31日至2022年1月12日獲得的與收益相關的政府補助共計2821.28萬元。

根據《企業會計準則第16號——政府補助》等相關規定,上述公司及子公司獲得的政府補助屬於與收益相關的政府補助。由於部分政府補助項目存在驗收條件,需在滿足相關條件後才能計入當期損益,因此預計上述政府補助對公司2021年度及後年度的利潤將產生一定的積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account